Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Diffuse Intrinsic Pontine Glioma × Drug Tolerance × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Brain Neoplasms 1

Interventions

Radiotherapy 5 Radiation 3 Panobinostat 3 Cyclophosphamide 3 ribociclib 2 Temozolomide 2 Everolimus 2 Etoposide 2 Dasatinib 2 vandetanib 1 temsirolimus 1 spartalizumab 1 sargramostim 1 reolysin 1 pembrolizumab 1 ovex 1 marizomib 1 irinotecan sucrosofate 1 gallium maltolate 1 etoposide phosphate 1 crenolanib 1 balstilimab 1 adavosertib 1 abemaciclib 1 Vorinostat 1 Vaccines 1 Topotecan 1 TIC10 compound 1 Standard of Care 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04771897 2024-12-20

KONQUER

Bexion Pharmaceuticals, Inc.

Phase 1 Terminated

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡